<DOC>
	<DOCNO>NCT01231295</DOCNO>
	<brief_summary>The primary objective study characterize cerebral metabolism modification use 18F-FDG PET technology perfusion 99MTC-ECD SPECT patient prodromal Alzheimer 's Disease drawn high risk population . We also compare PET SPECT image within framework , search optimal diagnostic threshold .</brief_summary>
	<brief_title>Isotopic Imaging Prodromal Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Inclusion Criteria group memory problem : patient consult memory problem caucasian memory complaint validate clinical evaluation cognitive performance sufficiently well preserve diagnostic dementia make ( accord DSMIVR NINCDSADRDA criterion ) time inclusion patient speak French presence informant accepts sign consent Inclusion Criteria group without memory problem ( reference population ) : least four year formal education patient consult memory problem memory problem report patient validated consultation , battery test specify screen presence informant Clinical Dementia Rating ( CDR ) = 0 accepts sign consent Instrumental Activities Daily Living ( IADL ) : least two item &gt; 1 Anticholinesterasic treatment and/or memantin study inclusion major depressive syndrome , accord Global Depressive Scale Known neurodegenerative disease general disease major physical problem could interfere cognitive function test Pathology might lead death short term ( evolve cancer , non stable cardiopathy , hepatic , renal respiratory insufficiency ) contraindication MRI , PET SPECT scan affiliated social security regimen</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>